Akanda (AKAN) Other Accumulated Expenses (2021)
Akanda's (AKAN) quarterly Other Accumulated Expenses came in at $496428.0 in Q4 2021.
Akanda (AKAN) Other Accumulated Expenses (2021) Analysis & Trends
Akanda's Other Accumulated Expenses history runs 1 years deep, the most recent figure standing at $496428.0 for Q4 2021.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $496428.0 in Q4 2021; TTM through Dec 2021 was $496428.0, a N/A change from a year earlier, with the FY2021 full-year figure at $496428.0, changed N/A from the prior year.
- Other Accumulated Expenses was $496428.0 for Q4 2021 at Akanda.
- Over the last five years, Other Accumulated Expenses for AKAN reached as high as $496428.0 in Q4 2021 and fell as low as $496428.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Akanda | 996.67 Mn | 996.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 496,428.00 |